Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification?

被引:16
作者
Benda, RK
Cendan, JC
Copeland, EM
Feezor, RJ
Lind, DS
Morris, CG
Mendenhall, NP
机构
[1] Univ Florida, Hlth Sci Ctr, Coll Med, Dept Radiat Oncol, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA
关键词
lymph nodes; breast neoplasms; drainage; radiotherapy;
D O I
10.1002/cncr.11918
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
BACKGROUND. Treatment of internal mammary lymph node (IMN) metastases remains controversial because of the difficulty in predicting involvement, potential treatment-related morbidity, and questionable efficacy. Lymphoscintigraphy with sentinel lymph node biopsy offers a means to identify occult involvement of IMN, allowing appropriate patient selection for IMN treatment. METHODS. The authors retrospectively reviewed 262 lymphoscintigraphies (LS) of 248 patients treated at the University of Florida (Gainesville, FL) between 1998 and 2002. Tumor characteristics were assessed for their value in predicting IMN drainage and their association with IMN radiation. RESULTS. Lymph flow to the IMN was documented with LS in 23 of 262 tumor specimens (9%). Flow to the IMN was not correlated with any of the five factors: tumor location, tumor size, lymphovascular;invasion, pathologic lymph node status, and laterality of the involved breast (right vs. left breast). Identification of IMN flow increased from 5.7% to 10.1% with the use of a deep injection technique. IMN radiotherapy was used more frequently in patients with larger tumors (15 of 188 in Tis/T1 vs. 31 of 70 in T2-T4; P < 0.0001) and positive lymph nodes (17 of 91 in lymph node-negative patients vs. 28 of 66 in lymph node-positive patients; P < 0.0001). In patients with T2N0 tumors (n = 32), IMN radiotherapy was used more frequently with medial tumors (5 of 11 [45%]) than with lateral tumors (4 of 21 [19%]). CONCLUSIONS. The incidence of flow to the IMN documented with the current LS technique was low compared with other LS and extended radical mastectomy series. Histopathologic information was obtained for the sentinel IMN when IMN flow was identified on the LS. In the absence of histopathologic information, treatment decisions should continue to be based on clinical factors known to be correlated with occult IMN involvement.
引用
收藏
页码:518 / 523
页数:6
相关论文
共 29 条
[1]
LONG-TERM EFFECT OF INTERNAL MAMMARY CHAIN TREATMENT - RESULTS OF A MULTIVARIATE-ANALYSIS OF 1195 PATIENTS WITH OPERABLE BREAST-CANCER AND POSITIVE AXILLARY NODES [J].
ARRIAGADA, R ;
LE, MG ;
MOURIESSE, H ;
FONTAINE, F ;
DEWAR, J ;
ROCHARD, F ;
SPIELMANN, M ;
LACOUR, J ;
TUBIANA, M ;
SARRAZIN, D .
RADIOTHERAPY AND ONCOLOGY, 1988, 11 (03) :213-222
[2]
Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy [J].
Byrd, DR ;
Dunnwald, LK ;
Mankoff, DA ;
Anderson, BO ;
Moe, RE ;
Yeung, RS ;
Schubert, EK ;
Eary, JF .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (03) :234-240
[3]
CACERES E, 1967, SURG GYNECOL OBSTETR, V125, P337
[4]
Sentinel node biopsy in the evaluation of the internal mammary node chain in patients with breast cancer [J].
Carcoforo, P ;
Basaglia, E ;
Soliani, G ;
Bergossi, L ;
Corcione, S ;
Pozza, E ;
Feggi, L .
TUMORI JOURNAL, 2002, 88 (03) :S5-S7
[5]
INTERNAL MAMMARY NODE STATUS - A MAJOR PROGNOSTICATOR IN AXILLARY NODE-NEGATIVE BREAST-CANCER [J].
CODY, HS ;
URBAN, JA .
ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (01) :32-37
[6]
CAUSE-SPECIFIC MORTALITY IN LONG-TERM SURVIVORS OF BREAST-CANCER WHO PARTICIPATED IN TRIALS OF RADIOTHERAPY [J].
CUZICK, J ;
STEWART, H ;
RUTQVIST, L ;
HOUGHTON, J ;
EDWARDS, R ;
REDMOND, C ;
PETO, R ;
BAUM, M ;
FISHER, B ;
HOST, H ;
LYTHGOE, J ;
RIBEIRO, G ;
SCHEURLEN, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :447-453
[7]
DONEGAN WL, 1977, CANCER-AM CANCER SOC, V39, P533, DOI 10.1002/1097-0142(197702)39:2<533::AID-CNCR2820390222>3.0.CO
[8]
2-V
[9]
Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer [J].
Fowble, B ;
Hanlon, A ;
Freedman, G ;
Nicolaou, N ;
Hoffman, J ;
Sigurdson, E ;
Boraas, M ;
Torosian, M ;
Goldstein, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04) :883-894
[10]
HANDLEY RS, 1975, ANN ROY COLL SURG, V57, P59